All Type of News
Small- and medium-sized pharmaceutical firms to face bumpy road
Influenced by the rapidly changing outer environments surrounding domestic pharmaceutical industry, such as free trade agreements, positive list system for pharmaceuticals and imminent introduction of advanced good ma...
1,419 items re-evaluated in 2007
The Korea Food and Drug Administration announced that a total of 1,419 items from 13 therapeutic categories, including antineoplastic agents, miscellaneous agents for treatment and diagnostics and chemotherapeutics, w...
Umckamin solution, an effective therapeutic option in acute and exacerbating bronchitis
The efficacy and tolerability of Umckamin (Pelargonium sidoides), which was launched by Yuyu Pharm last November, has been demonstrated in a recent clinical trial of 103 patients suffering from acute bronchitis or acu...
Bepanthol Snow Festival to be held
Bayer Healthcare plans to hold its Bepanthol (dexpanthenol) Snow Festival as part of efforts to promote the lip care product among skiers. It will take place from January 11 to 13 at Hyundai Sungwoo Resort at Hengsung...
Korea, China to promote bioindustrial collaboration
China aims to promote its bioindustrial collaboration with Korea by dispatching 12 representatives from industry and research institutes to the Korea to the oncoming Biocluster Networking Session and Biobusiness Partn...
Drug makers come up with aggressive OTC sales plan
The majority of local pharmaceutical firms set forth their business plans for 2008, largely characterized by aggressive OTC sales with all-out incentive plans, amid concerns over expected sluggish ethical sales under ...
KFDA approves Galvus, new oral treatment for type 2 diabetesNovartis Korea says the Korea Food and Drug Administration (KFDA) has approved Galvus (vildagliptin), a new oral treatment for type 2 diabetes.
As a member of the new class o...
|
Monthly reporting of drug shipments set to be delayed until October
The obligatory monthly reporting of drug shipments by pharmaceutical firms and wholesalers, which would take place in January, is likely to be deferred until this October, according to the Drug Management Information ...
Big 3 medicinal patch makers eye pharmacy market
Stimulated by the government's plan that medicinal patch preparations would not covered by the national insurance fund sooner or later, three leading drug makers Pacific Pharm, Jeil Pharm and SK Chemicals plan to ex...
Yuhan's 10 medicines break 10-billion mark in 2007 sales
Yuhan Corporation's ten flagship products exceeded 10-billion sales last year, propelled by strong demand in related sectors.
Of these items, Yuhan's new drug Revanex (revaprazan) surpassed a 10 billion mark in...
